Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The combination treatment showed a higher response rate but no significant survival benefits.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

A cat with hair loss and illness was found to have cancer spread from its colon.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Targeting FGF5 could help treat prostate cancer.

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Early treatment is important for better hair regrowth in elderly women with hair loss.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.